Please leave this field empty
(800) 458-6223
Select Page

CureSearch Announces New Scientific Advisory Council Chair

Posted: February 20, 2015

Christine Bork
Chief Development and Communications Officer
(240) 235-2208 |

February 17, 2015

CureSearch announced today the appointment of Memorial Sloan Kettering Cancer Center Department of Pediatrics Chair, Dr. Richard J. O’Reilly, as their Scientific Advisory Council Chair.

Richard O'Reilly, MDBethesda, Md, February 17, 2015, CureSearch for Children’s Cancer – a nonprofit organization focused on ending children’s cancer by driving targeted and innovative research – announced today the appointment of Memorial Sloan Kettering Cancer Center Department of Pediatrics Chair, Dr. Richard J. O’Reilly as Chairman of its Scientific Advisory Council (SAC). The SAC is a group of leading researchers, oncologists and experts in their respective fields who make recommendations to guide the organization’s scientific strategy, agenda and grants program.

In addition to serving as the Department of Pediatrics Chair at Memorial Sloan Kettering Cancer Center, Dr. O’Reilly is Chief, Pediatric Bone Marrow Transplant Service; Claire L. Tow Chair in Pediatric Oncology Research; and bone marrow transplant and immunological deficiencies expert. The field-recognized Dr. O’Reilly has received honors from the American Society of Clinical Oncology; the Society of Translational Oncology; the American Society for Blood and Marrow Transplantation; and Leiden University in The Netherlands.

“I support CureSearch because of its focus on research into childhood malignancies and the development of better approaches to control or cure these diseases while preserving the child,” said Dr. Richard J. O’Reilly. “Research supported is inherently focused on translation and particularly translation to children with cancer who are too often therapeutic orphans.”

“Like our two previous SAC Chairs, in order to ensure we are asking the right questions as we consider how to best drive research, we need trailblazers in the field of pediatric oncology to identify the greatest challenges impeding the search for cures. Because Dr. O’Reilly is not only a pioneer, but also a leader in pediatric oncology for the past several decades, we can count on him to provide credibility and experience,” said Dr. Stuart Siegel, CureSearch board chair.

“We are honored to have him not only join the Scientific Advisory Council, but take on the role of Chair, and are certain he will help guide our programs and strategy to a level of distinction,” added Laura Thrall, chief executive officer of CureSearch.

CureSearch looks to its SAC for guidance on accelerating research from the science lab to the child’s bedside as quickly as possible. The SAC supports CureSearch’s mission to drive research aimed at eliminating research barriers and solving the field’s most challenging problems, particularly around toxicity that has profound and lasting impact on children with cancer.

The other members of the Scientific Advisory Council are:

  • William L. Carroll, MD: Julie and Edward J. Minskoff Professor of Pediatrics Director, NYU Cancer Institute in New York, NY
  • James E Bradner, MD: Assistant Professor, Department of Medicine Harvard Medical School; Attending Physician, Hematologic Neoplasia at the Dana-Farber Cancer Institute; Associate Director, Center for the Science of Therapeutics Broad Institute in Boston, MA
  • Richard Gilbertson, MD, PhD: Director of Comprehensive Cancer Center; Executive Vice President; Director of the Division of Brain Tumor Research, St. Jude Children’s Research Hospital in Memphis, TN
  • Alexander R. Judkins, MD: Pathologist-in-Chief and Department Head, Department of Pathology and Laboratory Medicine at Children’s Hospital of Los Angeles; Vice Chair of Department of Pathology; Keck School of Medicine of USC in Los Angeles, CA
  • A. Thomas Look, MD: Professor, Department of Pediatrics, Harvard Medical School; Vice-Chair for Research, Pediatric Oncology at the Dana-Farber Cancer Institute in Boston, MA
  • Brad H. Pollock, MPH, PhD: Professor and Chairman, Epidemiology & Biostatistics, University of Texas Health Science Center at San Antonio in San Antonio, TX
  • Kathleen Ruccione, MPH, RN, FAAN: Co-Director, HOPE Program, Children’s Hospital of Los Angeles in Los Angeles, CA
  • Nita Seibel, MD: Head, Pediatric Solid Tumors, National Cancer Institute in Bethesda, MD

CureSearch for Children’s Cancer, a national nonprofit organization based in Bethesda, Md, works to end childhood cancer by driving targeted and innovative research with measureable results in an accelerated time frame. CureSearch is building a $10 million research pipeline to aggressively drive pediatric research grants and clinical trials that have a higher chance of becoming cures for children’s cancer without the toxic side effects that plague current treatment options.

CureSearch Announces New Scientific Advisory Council Chair was last modified: August 5th, 2016 by Geoff Duncan


Pin It on Pinterest